Genelux Corporation (Genelux)

Oncology Corporate Profile

HQ Location

3030 Bunker Hill St Ste 310
San Diego, CA 92109

Company Description

Genelux Corporation is a privately held, clinical stage biopharmaceutical company dedicated to fundamentally changing the way in which cancer is diagnosed and treated. The company has developed a proprietary oncolytic vaccinia virus based technology platform that can be engineered to insert specific therapeutic genes for delivery and amplification of anti-cancer proteins and RNA into cancer cells without harming healthy cells.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GL-ONC1oncolytic virus immunomodulatorVarious cancer typesII
GL-ONC1oncolytic virus immunomodulatorHead & Neck cancerI
GL-ONC1oncolytic virus immunomodulatorLung cancerI
GL-ONC1oncolytic virus immunomodulatorMesotheliomaI
GL-ONC3oncolytic virus immunomodulatorPancreatic cancerPreclinical
GL-ONC2oncolytic virus immunomodulatorPancreatic cancerPreclinical
GL-ONC4oncolytic virus immunomodulatorProstate cancerPreclinical
GL-ONC2oncolytic virus immunomodulatorThyroid cancerPreclinical
GL-ONC4oncolytic virus immunomodulatorVarious cancer typesPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display